Loading…
Lobbying Spend
—
Filings
56
Firms Hired
1
Active Period
2009–2022
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
To amend title XVIII of the Social Security Act to create care management demonstration programs for chronic kidney disease under the Medicare program, and for other purposes.
2018 · fourth_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patient Living Donor Protections Federal Funding for Medical Research H.R.3867 - To amend title XVIII of the Social Security Act to create care management demonstration programs for chronic kidney disease under the Medicare program, and for other purposes Dialysis PATIENTS Demonstration Act of 2017
Client expense: — · Firm income: $60,000
Matched citations: H.R.3867
To amend title XVIII of the Social Security Act to create care management demonstration programs for chronic kidney disease under the Medicare program, and for other purposes.
2018 · third_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patient Living Donor Protections Hospital Readmissions & Transplant Patients Federal Funding for Medical Research H.R.3867 - To amend title XVIII of the Social Security Act to create care management demonstration programs for chronic kidney disease under the Medicare program, and for other purposes Dialysis PATIENTS Demonstration Act of 2017
Client expense: — · Firm income: $60,000
Matched citations: H.R.3867
To amend title XVIII of the Social Security Act to create care management demonstration programs for chronic kidney disease under the Medicare program, and for other purposes.
2018 · second_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patient Living Donor Protections Hospital Readmissions & Transplant Patients Federal Funding for Medical Research H.R.3867 - To amend title XVIII of the Social Security Act to create care management demonstration programs for chronic kidney disease under the Medicare program, and for other purposes Dialysis PATIENTS Demonstration Act of 2017
Client expense: — · Firm income: $60,000
Matched citations: H.R.3867
To amend title XVIII of the Social Security Act to create care management demonstration programs for chronic kidney disease under the Medicare program, and for other purposes.
2018 · first_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patient Living Donor Protections Hospital Readmissions & Transplant Patients Federal Funding for Medical Research H.R.3867 - To amend title XVIII of the Social Security Act to create care management demonstration programs for chronic kidney disease under the Medicare program, and for other purposes Dialysis PATIENTS Demonstration Act of 2017
Client expense: — · Firm income: $60,000
Matched citations: H.R.3867
To amend title XVIII of the Social Security Act to create care management demonstration programs for chronic kidney disease under the Medicare program, and for other purposes.
2017 · fourth_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patient Living Donor Protections Hospital Readmissions & Transplant Patients Federal Funding for Medical Research H.R.3867 - To amend title XVIII of the Social Security Act to create care management demonstration programs for chronic kidney disease under the Medicare program, and for other purposes Dialysis PATIENTS Demonstration Act of 2017
Client expense: — · Firm income: $60,000
Matched citations: H.R.3867
To amend title XVIII of the Social Security Act to create care management demonstration programs for chronic kidney disease under the Medicare program, and for other purposes.
2017 · third_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patient Living Donor Protections Hospital Readmissions & Transplant Patients Federal Funding for Medical Research H.R.3867 - To amend title XVIII of the Social Security Act to create care management demonstration programs for chronic kidney disease under the Medicare program, and for other purposes
Client expense: — · Firm income: $60,000
Matched citations: H.R.3867
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
2014 · fourth_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
HR 1325/S 323 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act Living Donor Registry HR 698/S 330 HIV Organ Policy Equity Act Blood Safety Issues
Client expense: — · Firm income: $60,000
Matched citations: HR 1325
HIV Organ Policy Equity Act
2014 · fourth_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
HR 1325/S 323 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act Living Donor Registry HR 698/S 330 HIV Organ Policy Equity Act Blood Safety Issues
Client expense: — · Firm income: $60,000
Matched citations: HR 698
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
2014 · fourth_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
HR 1325/S 323 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act Living Donor Registry HR 698/S 330 HIV Organ Policy Equity Act Blood Safety Issues
Client expense: — · Firm income: $60,000
Matched citations: S 323
HIV Organ Policy Equity Act
2014 · fourth_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
HR 1325/S 323 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act Living Donor Registry HR 698/S 330 HIV Organ Policy Equity Act Blood Safety Issues
Client expense: — · Firm income: $60,000
Matched citations: S 330
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
2014 · third_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
HR 1325/S 323 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act; Living Donor Registry; HR 698/S 330 HIV Organ Policy Equity Act ; Blood Safety Issues
Client expense: — · Firm income: $60,000
Matched citations: HR 1325
HIV Organ Policy Equity Act
2014 · third_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
HR 1325/S 323 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act; Living Donor Registry; HR 698/S 330 HIV Organ Policy Equity Act ; Blood Safety Issues
Client expense: — · Firm income: $60,000
Matched citations: HR 698
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
2014 · third_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
HR 1325/S 323 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act; Living Donor Registry; HR 698/S 330 HIV Organ Policy Equity Act ; Blood Safety Issues
Client expense: — · Firm income: $60,000
Matched citations: S 323
HIV Organ Policy Equity Act
2014 · third_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
HR 1325/S 323 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act; Living Donor Registry; HR 698/S 330 HIV Organ Policy Equity Act ; Blood Safety Issues
Client expense: — · Firm income: $60,000
Matched citations: S 330
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
2014 · second_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
HR 1325/S 323 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act; Living Donor Registry; HR 698/S 330 HIV Organ Policy Equity Act ; Blood Safety Issues
Client expense: — · Firm income: $60,000
Matched citations: HR 1325
HIV Organ Policy Equity Act
2014 · second_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
HR 1325/S 323 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act; Living Donor Registry; HR 698/S 330 HIV Organ Policy Equity Act ; Blood Safety Issues
Client expense: — · Firm income: $60,000
Matched citations: HR 698
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
2014 · second_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
HR 1325/S 323 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act; Living Donor Registry; HR 698/S 330 HIV Organ Policy Equity Act ; Blood Safety Issues
Client expense: — · Firm income: $60,000
Matched citations: S 323
HIV Organ Policy Equity Act
2014 · second_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
HR 1325/S 323 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act; Living Donor Registry; HR 698/S 330 HIV Organ Policy Equity Act ; Blood Safety Issues
Client expense: — · Firm income: $60,000
Matched citations: S 330
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
2014 · first_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
HR 1325/S 323 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act; Living Donor Registry; HR 698/S 330 HIV Organ Policy Equity Act; Blood Safety Issues
Client expense: — · Firm income: $60,000
Matched citations: HR 1325
HIV Organ Policy Equity Act
2014 · first_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
HR 1325/S 323 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act; Living Donor Registry; HR 698/S 330 HIV Organ Policy Equity Act; Blood Safety Issues
Client expense: — · Firm income: $60,000
Matched citations: HR 698
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
2014 · first_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
HR 1325/S 323 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act; Living Donor Registry; HR 698/S 330 HIV Organ Policy Equity Act; Blood Safety Issues
Client expense: — · Firm income: $60,000
Matched citations: S 323
HIV Organ Policy Equity Act
2014 · first_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
HR 1325/S 323 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act; Living Donor Registry; HR 698/S 330 HIV Organ Policy Equity Act; Blood Safety Issues
Client expense: — · Firm income: $60,000
Matched citations: S 330
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
2013 · fourth_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
HR 1325/S 323 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act; Living Donor Registry; HR 698/S 330 HIV Organ Policy Equity Act ; Blood Safety Issues
Client expense: — · Firm income: $60,000
Matched citations: HR 1325
HIV Organ Policy Equity Act
2013 · fourth_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
HR 1325/S 323 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act; Living Donor Registry; HR 698/S 330 HIV Organ Policy Equity Act ; Blood Safety Issues
Client expense: — · Firm income: $60,000
Matched citations: HR 698
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
2013 · fourth_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
HR 1325/S 323 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act; Living Donor Registry; HR 698/S 330 HIV Organ Policy Equity Act ; Blood Safety Issues
Client expense: — · Firm income: $60,000
Matched citations: S 323
Source: Senate LDA